{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T15:37:12Z","timestamp":1790696232886,"version":"4.1.0"},"reference-count":224,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Deputy of Research, Tehran University of Medical Sciences","award":["94-01-41-28875"],"award-info":[{"award-number":["94-01-41-28875"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.imlet.2017.11.004","type":"journal-article","created":{"date-parts":[[2017,11,20]],"date-time":"2017-11-20T05:18:25Z","timestamp":1511155105000},"page":"14-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"special_numbering":"C","title":["Survivin and autoimmunity; the ins and outs"],"prefix":"10.1016","volume":"193","author":[{"given":"Hamidreza","family":"Ebrahimiyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Rezaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdi","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0005","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrc968","article-title":"Validating survivin as a cancer therapeutic target","volume":"3","author":"Altieri","year":"2003","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0010","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1084\/jem.20031588","article-title":"Essential role of survivin, an inhibitor of apoptosis protein, in T cell development, maturation, and homeostasis","volume":"199","author":"Xing","year":"2004","journal-title":"J. Exp. Med."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0015","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1182\/blood-2011-03-342428","article-title":"Blockade of prostaglandin E2 signaling through EP1 and EP3 receptors attenuates Flt3L-dependent dendritic cell development from hematopoietic progenitor cells","volume":"119","author":"Singh","year":"2012","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0020","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1002\/eji.201243081","article-title":"Transgenic expression of survivin compensates for OX40-deficiency in driving Th2 development and allergic inflammation","volume":"43","author":"Lei","year":"2013","journal-title":"Eur. J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0025","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0165-2478(01)00186-9","article-title":"Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells","volume":"76","author":"Kornacker","year":"2001","journal-title":"Immunol. Lett."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0030","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0198-8859(01)00369-X","article-title":"Developmentally regulated expression of survivin in the human thymus","volume":"63","author":"Kobayashi","year":"2002","journal-title":"Hum. Immunol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0035","doi-asserted-by":"crossref","first-page":"e47668","DOI":"10.1371\/journal.pone.0047668","article-title":"Activation of Fms-like tyrosine kinase 3 signaling enhances survivin expression in a mouse model of rheumatoid arthritis","volume":"7","author":"Andersson","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/70487","article-title":"Analysis of human transcriptomes","volume":"23","author":"Velculescu","year":"1999","journal-title":"Nat. Genet."},{"key":"10.1016\/j.imlet.2017.11.004_bib0045","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.immunol.17.1.221","article-title":"Mature T lymphocyte apoptosis\u2013immune regulation in a dynamic and unpredictable antigenic environment","volume":"17","author":"Lenardo","year":"1999","journal-title":"Annu. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2017.11.004_bib0050","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/nm0897-917","article-title":"A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma","volume":"3","author":"Ambrosini","year":"1997","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0055","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1476-4598-4-11","article-title":"Survivin 2alpha: a novel Survivin splice variant expressed in human malignancies","volume":"4","author":"Caldas","year":"2005","journal-title":"Mol. Cancer"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0060","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.bbrc.2003.12.178","article-title":"Identification of a novel splice variant of the human anti-apoptopsis gene survivin","volume":"314","author":"Badran","year":"2004","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"24","key":"10.1016\/j.imlet.2017.11.004_bib0065","first-page":"6097","article-title":"Survivin-deltaEx3 and survivin-2B: two novel splice variants of the apoptosis inhibitor survivin with different antiapoptotic properties","volume":"59","author":"Mahotka","year":"1999","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0070","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.3892\/ijo.2014.2544","article-title":"KLF5 promotes hypoxia-induced survival and inhibits apoptosis in non-small cell lung cancer cells via HIF-1alpha","volume":"45","author":"Li","year":"2014","journal-title":"Int. J. Oncol."},{"issue":"36","key":"10.1016\/j.imlet.2017.11.004_bib0075","doi-asserted-by":"crossref","first-page":"26202","DOI":"10.1074\/jbc.M700776200","article-title":"Degradation of survivin by the X-linked inhibitor of apoptosis (XIAP)-XAF1 complex","volume":"282","author":"Arora","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0080","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1042\/BJ20100814","article-title":"Survivin and IAP proteins in cell-death mechanisms","volume":"430","author":"Altieri","year":"2010","journal-title":"Biochem. J."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0085","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2016.11.094","article-title":"Survivin does not influence the anti-apoptotic action of XIAP on caspase-9","volume":"482","author":"Zumbragel","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0092-8674(00)00008-8","article-title":"Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition","volume":"102","author":"Du","year":"2000","journal-title":"Cell"},{"issue":"6711","key":"10.1016\/j.imlet.2017.11.004_bib0095","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/25141","article-title":"Control of apoptosis and mitotic spindle checkpoint by survivin","volume":"396","author":"Li","year":"1998","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.imlet.2017.11.004_bib0100","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/70242","article-title":"Pleiotropic cell-division defects and apoptosis induced by interference with survivin function","volume":"1","author":"Li","year":"1999","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0105","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.bbadis.2016.11.033","article-title":"Survivin controls biogenesis of microRNA in smokers: a link to pathogenesis of rheumatoid arthritis","volume":"1863","author":"Andersson","year":"2017","journal-title":"Biochim. et Biophys. Acta (BBA)-Mol. Basis Dis."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0110","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1038\/sj.onc.1208350","article-title":"Survivin splice variants regulate the balance between proliferation and cell death","volume":"24","author":"Caldas","year":"2005","journal-title":"Oncogene"},{"issue":"45","key":"10.1016\/j.imlet.2017.11.004_bib0115","doi-asserted-by":"crossref","first-page":"7545","DOI":"10.1038\/sj.onc.1208038","article-title":"An alternatively spliced survivin variant is positively regulated by p53 and sensitizes leukemia cells to chemotherapy","volume":"23","author":"Zhu","year":"2004","journal-title":"Oncogene"},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0120","first-page":"891","article-title":"Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas","volume":"13","author":"Suga","year":"2005","journal-title":"Oncol. Rep."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0125","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/sj.bjc.6600153","article-title":"Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression","volume":"86","author":"Krieg","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0130","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.lungcan.2005.03.037","article-title":"Differential expression of survivin-2\u2009B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC)","volume":"49","author":"Ling","year":"2005","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"10.1016\/j.imlet.2017.11.004_bib0135","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s13075-015-0689-z","article-title":"Suppressed diversity of survivin splicing in active rheumatoid arthritis","volume":"17","author":"Turkkila","year":"2015","journal-title":"Arthritis. Res. Ther."},{"key":"10.1016\/j.imlet.2017.11.004_bib0140","doi-asserted-by":"crossref","first-page":"9795","DOI":"10.1038\/srep09795","article-title":"The proto-oncogene survivin splice variant 2B is induced by PDGF and leads to cell proliferation in rheumatoid arthritis fibroblast-like synoviocytes","volume":"5","author":"Mokuda","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.imlet.2017.11.004_bib0145","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int."},{"issue":"53","key":"10.1016\/j.imlet.2017.11.004_bib0150","doi-asserted-by":"crossref","first-page":"8581","DOI":"10.1038\/sj.onc.1207113","article-title":"Survivin, versatile modulation of cell division and apoptosis in cancer","volume":"22","author":"Altieri","year":"2003","journal-title":"Oncogene"},{"issue":"14","key":"10.1016\/j.imlet.2017.11.004_bib0155","doi-asserted-by":"crossref","first-page":"23937","DOI":"10.18632\/oncotarget.14893","article-title":"Aurora kinases: novel therapy targets in cancers","volume":"8","author":"Tang","year":"2017","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0160","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1002\/jcp.21875","article-title":"expression in post-puberal testicular germ cell tumours","volume":"221","author":"Esposito","year":"2009","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0165","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.immuni.2005.03.012","article-title":"Sustained survivin expression from OX40 costimulatory signals drives T cell clonal expansion","volume":"22","author":"Song","year":"2005","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0170","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.4049\/jimmunol.1501690","article-title":"Essential role for survivin in the proliferative expansion of progenitor and mature B cells","volume":"196","author":"Miletic","year":"2016","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0175","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.3892\/mmr.2015.3579","article-title":"Optimized generation of survivin-specific cytotoxic T lymphocytes against lung cancer","volume":"12","author":"Li","year":"2015","journal-title":"Mol. Med. Rep."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0180","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1038\/nm1474","article-title":"LEF-1 is crucial for neutrophil granulocytopoiesis and its expression is severely reduced in congenital neutropenia","volume":"12","author":"Skokowa","year":"2006","journal-title":"Nat. Med."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0185","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1084\/jem.20032033","article-title":"Inflammation-associated cell cycle-independent block of apoptosis by survivin in terminally differentiated neutrophils","volume":"199","author":"Altznauer","year":"2004","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0190","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1189\/jlb.0507282","article-title":"Terminally differentiated neutrophils predominantly express Survivin-2 alpha, a dominant-negative isoform of survivin","volume":"83","author":"Hu","year":"2008","journal-title":"J. Leukoc. Biol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0195","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12967-017-1141-8","article-title":"Immune modulation of some autoimmune diseases: the critical role of macrophages and neutrophils in the innate and adaptive immunity","volume":"15","author":"Navegantes","year":"2017","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0200","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jcp.10327","article-title":"Survivin study: what is the next wave?","volume":"197","author":"Li","year":"2003","journal-title":"J. Cell. Physiol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0205","doi-asserted-by":"crossref","first-page":"9745","DOI":"10.1074\/jbc.M409350200","article-title":"Molecular mechanism of inhibition of survivin transcription by the GC-rich sequence-selective DNA binding antitumor agent, hedamycin: evidence of survivin down-regulation associated with drug sensitivity","volume":"280","author":"Wu","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.imlet.2017.11.004_bib0210","series-title":"Survivin in Autoimmune Diseases, Autoimmunity Reviews","author":"Gravina","year":"2017"},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0215","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1177\/00220345920710121201","article-title":"Suppressor cell function in oral lichen planus","volume":"71","author":"Sugerman","year":"1992","journal-title":"J. Dent. Res."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0220","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1046\/j.1365-2133.2000.03355.x","article-title":"Autocytotoxic T-cell clones in lichen planus","volume":"142","author":"Sugerman","year":"2000","journal-title":"Br. J. Dermatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0225","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1440-0960.1993.tb00860.x","article-title":"Disease mechanisms in oral lichen planus. A possible role for autoimmunity","volume":"34","author":"Sugerman","year":"1993","journal-title":"Australas. J. Dermatol."},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2017.11.004_bib0230","first-page":"1","article-title":"Characterization of mononuclear cells of inflammatory infiltrates in oral tissues. A histochemical and immunohistochemical study of labial salivary glands in Sjogren's syndrome and of oral lesions in systemic lupus erythematosus and in lichen planus","volume":"84","author":"Kilpi","year":"1988","journal-title":"Proc. Finnish Dental Soc. Suomen Hammaslaakariseuran toimituksia"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0235","first-page":"174","article-title":"Activation marker analysis of mononuclear cell infiltrates of oral lichen planus in situ","volume":"95","author":"Kilpi","year":"1987","journal-title":"Scand. J. Dent. Res."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0240","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1365-2133.1984.tb06629.x","article-title":"Oral lichen planus: an immunoperoxidase study using monoclonal antibodies to lymphocyte subsets","volume":"111","author":"Matthews","year":"1984","journal-title":"Br. J. Dermatol."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0245","first-page":"361","article-title":"Immunoelectron microscopic study of distribution of T cell subsets in oral lichen planus","volume":"97","author":"Jungell","year":"1989","journal-title":"Scand. J. Dent. Res."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0250","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1034\/j.1600-0714.2003.00077.x","article-title":"Th1 cytokines in oral lichen planus","volume":"32","author":"Khan","year":"2003","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0255","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0714.1990.tb00801.x","article-title":"The activation of Langerhans cells in oral lichen planus","volume":"19","author":"Farthing","year":"1990","journal-title":"J. Oral Pathol. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0260","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1365-2133.1989.tb07786.x","article-title":"A quantitative assessment of Langerhans cells in oral mucosal lichen planus and leukoplakia","volume":"120","author":"Rich","year":"1989","journal-title":"Br. J. Dermatol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0265","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1600-0714.1998.tb01917.x","article-title":"Distribution of interferon-gamma mRNA-positive cells in oral lichen planus lesions","volume":"27","author":"Simark Mattsson","year":"1998","journal-title":"J. Oral Pathol. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0270","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0003-9969(99)00013-8","article-title":"Distribution of interleukin-2, \u22124, \u221210, tumour necrosis factor-alpha and transforming growth factor-beta mRNAs in oral lichen planus","volume":"44","author":"Simark-Mattsson","year":"1999","journal-title":"Arch. Oral Biol."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib0275","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1053\/joms.2000.16629","article-title":"Oral lichen planus: a benign lesion","volume":"58","author":"Eisenberg","year":"2000","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib0280","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/joms.2000.16630","article-title":"Oral lichen planus: a potentially premalignant lesion","volume":"58","author":"Silverman","year":"2000","journal-title":"J. Oral Maxillofac. Surg."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0285","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.tripleo.2010.04.009","article-title":"Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance","volume":"110","author":"Liping","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endodontol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0290","doi-asserted-by":"crossref","first-page":"234","DOI":"10.4103\/0973-029X.185912","article-title":"Survivin expression in oral lichen planus: role in malignant transformation","volume":"20","author":"Suganya","year":"2016","journal-title":"J. Oral Maxillofacial Pathol.: JOMFP"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0295","doi-asserted-by":"crossref","first-page":"249","DOI":"10.6026\/97320630004248","article-title":"LCK, survivin and PI-3 K in the molecular biomarker profiling of oral lichen planus and oral squamous cell carcinoma","volume":"4","author":"Oluwadara","year":"2009","journal-title":"Bioinformation"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0300","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","article-title":"Synovial fibroblasts: key players in rheumatoid arthritis","volume":"45","author":"Huber","year":"2006","journal-title":"Rheumatology (Oxford England)"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","article-title":"Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis","volume":"233","author":"Bartok","year":"2010","journal-title":"Immunol. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0310","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1017\/S1463423612000072","article-title":"Current osteoarthritis treatment, prescribing influences and barriers to implementation in primary care","volume":"13","author":"Kingsbury","year":"2012","journal-title":"Primary Health Care Res. Dev."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0315","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mcna.2008.08.009","article-title":"Etiopathogenesis of osteoarthritis","volume":"93","author":"Brandt","year":"2009","journal-title":"Med. Clinics North Am."},{"issue":"9746","key":"10.1016\/j.imlet.2017.11.004_bib0320","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet (London England)"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0325","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1053\/sarh.2001.27719","article-title":"Cigarette smoking and rheumatoid arthritis","volume":"31","author":"Albano","year":"2001","journal-title":"Semin. Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0330","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/RHU.0b013e31820edd18","article-title":"Vitamin D, immunoregulation, and rheumatoid arthritis","volume":"17","author":"Wen","year":"2011","journal-title":"J. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0335","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa073491","article-title":"TRAF1-C5 as a risk locus for rheumatoid arthritis?a genomewide study","volume":"357","author":"Plenge","year":"2007","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0340","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1073\/pnas.93.1.221","article-title":"Differentiation of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis","volume":"93","author":"Schroder","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0345","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/j.1365-3083.1995.tb03596.x","article-title":"The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue","volume":"41","author":"Randen","year":"1995","journal-title":"Scand. J. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0350","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.162.5.3053","article-title":"Plasma cell development in synovial germinal centers in patients with rheumatoid and reactive arthritis","volume":"162","author":"Kim","year":"1999","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0355","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/1529-0131(199812)41:12<2211::AID-ART17>3.0.CO;2-O","article-title":"Functional analysis of rheumatoid factor-producing B cells from the synovial fluid of rheumatoid arthritis patients","volume":"41","author":"Reparon-Schuijt","year":"1998","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0360","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/oxfordjournals.bmb.a072971","article-title":"Immunology of systemic rheumatoid disease","volume":"51","author":"Snowden","year":"1995","journal-title":"Br. Med. Bull."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0365","first-page":"82","article-title":"Expression of vascular cell adhesion molecule-1 in normal and inflamed synovium","volume":"68","author":"Wilkinson","year":"1993","journal-title":"Lab. Invest."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0370","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s11926-009-0052-y","article-title":"The role of interleukin-17 in the pathogenesis of rheumatoid arthritis","volume":"11","author":"Gaffen","year":"2009","journal-title":"Curr. Rheumatol. Rep."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0375","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.rdc.2010.02.006","article-title":"Targeting IL-17 and Th17 cells in rheumatoid arthritis","volume":"36","author":"Sarkar","year":"2010","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2017.11.004_bib0380","doi-asserted-by":"crossref","first-page":"iii29","DOI":"10.1136\/ard.2006.058529","article-title":"Potential new targets in arthritis therapy: interleukin (IL)-17 and its relation to tumour necrosis factor and IL-1 in experimental arthritis","volume":"65","author":"Koenders","year":"2006","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0385","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1440-1711.2004.01212.x","article-title":"Interleukin-17: the missing link between T-cell accumulation and effector cell actions in rheumatoid arthritis?","volume":"82","author":"Stamp","year":"2004","journal-title":"Immunol. Cell Biol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0390","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-3083.1992.tb03260.x","article-title":"T cells cloned from human rheumatoid synovial membrane functionally represent the Th1 subset","volume":"35","author":"Miltenburg","year":"1992","journal-title":"Scand. J. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0395","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1038\/nm.2050","article-title":"Synovial fibroblasts spread rheumatoid arthritis to unaffected joints","volume":"15","author":"Lefevre","year":"2009","journal-title":"Nat. Med."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0400","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1002\/art.21118","article-title":"Invasiveness of fibroblast-like synoviocytes is an individual patient characteristic associated with the rate of joint destruction in patients with rheumatoid arthritis","volume":"52","author":"Tolboom","year":"2005","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0405","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.rdc.2012.05.003","article-title":"Initial management of rheumatoid arthritis","volume":"38","author":"Gramling","year":"2012","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0410","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cyto.2010.10.010","article-title":"Lymphotoxin alpha stimulates proliferation and pro-inflammatory cytokine secretion of rheumatoid arthritis synovial fibroblasts","volume":"53","author":"Calmon-Hamaty","year":"2011","journal-title":"Cytokine"},{"issue":"23","key":"10.1016\/j.imlet.2017.11.004_bib0415","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1016\/j.febslet.2011.06.006","article-title":"Citrullination of autoantigens: upstream of TNFalpha in the pathogenesis of rheumatoid arthritis","volume":"585","author":"Quirke","year":"2011","journal-title":"FEBS Lett."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0420","first-page":"447","article-title":"Precipitating and perpetuating factors of rheumatoid arthritis immunopathology: linking the triad of genetic predisposition, environmental risk factors and autoimmunity to disease pathogenesis, Best practice & research","volume":"25","author":"Scott","year":"2011","journal-title":"Clin. Rheumatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0425","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jbspin.2011.07.006","article-title":"PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients","volume":"79","author":"Abd-Allah","year":"2012","journal-title":"Joint, Bone, Spine: revue du rhumatisme"},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0430","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1101\/gad.2037511","article-title":"CpG islands and the regulation of transcription","volume":"25","author":"Deaton","year":"2011","journal-title":"Genes. Dev."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0435","first-page":"534","article-title":"MicroRNAs, the immune system and rheumatic disease, Nature clinical practice","volume":"4","author":"Tili","year":"2008","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0440","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1189\/jlb.3A0714-317R","article-title":"Down-regulation of survivin alleviates experimental arthritis","volume":"97","author":"Andersson","year":"2015","journal-title":"J. Leukoc. Biol."},{"issue":"24","key":"10.1016\/j.imlet.2017.11.004_bib0445","doi-asserted-by":"crossref","first-page":"20043","DOI":"10.18632\/oncotarget.4994","article-title":"Survivin co-ordinates formation of follicular T-cells acting in synergy with Bcl-6","volume":"6","author":"Andersson","year":"2015","journal-title":"Oncotarget"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0450","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1186\/ar4474","article-title":"Survivin but not Fms-like tyrosine kinase 3 ligand is up-regulated before the onset of rheumatoid arthritis: a pilot study","volume":"16","author":"Bokarewa","year":"2014","journal-title":"Arthritis. Res. Ther."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0455","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1189\/jlb.0507287","article-title":"Extracellular survivin up-regulates adhesion molecules on the surface of leukocytes changing their reactivity pattern","volume":"83","author":"Mera","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2017.11.004_bib0460","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1186\/s12916-015-0485-2","article-title":"Serum survivin predicts responses to treatment in active rheumatoid arthritis: a post hoc analysis from the SWEFOT trial","volume":"13","author":"Levitsky","year":"2015","journal-title":"BMC Med."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0465","doi-asserted-by":"crossref","first-page":"e468","DOI":"10.1097\/MD.0000000000000468","article-title":"Recognizing rheumatoid arthritis: oncoprotein survivin opens new possibilities: a population-based case-control study","volume":"94","author":"Chun-Lai","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0470","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3109\/07853890903376280","article-title":"Increased expression of proto-oncogene survivin predicts Joint destruction and persistent disease activity in early rheumatoid arthritis","volume":"42","author":"Svensson","year":"2010","journal-title":"Ann. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0475","doi-asserted-by":"crossref","first-page":"R349","DOI":"10.1186\/ar1498","article-title":"Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis","volume":"7","author":"Bokarewa","year":"2005","journal-title":"Arthritis. Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0480","first-page":"881","article-title":"Relationship of angiogenic factors to disease activity and radiographic damage in rheumatoid arthritis","volume":"26","author":"Park","year":"2008","journal-title":"Clin. Exp. Rheumatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0485","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10753-010-9196-1","article-title":"Increased extracellular survivin in the synovial fluid of rheumatoid arthritis patients: fibroblast-like synoviocytes as a potential source of extracellular survivin","volume":"33","author":"Ahn","year":"2010","journal-title":"Inflammation"},{"issue":"9b","key":"10.1016\/j.imlet.2017.11.004_bib0490","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1111\/j.1582-4934.2009.00721.x","article-title":"Survivin is an essential mediator of arthritis interacting with urokinase signalling","volume":"13","author":"Baran","year":"2009","journal-title":"J. Cell. Mol. Med."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0495","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/rheumatology\/kep467","article-title":"Apoptosis in the rheumatoid arthritis synovial membrane: modulation by disease-modifying anti-rheumatic drug treatment","volume":"49","author":"Smith","year":"2010","journal-title":"Rheumatology (Oxford England)"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0500","doi-asserted-by":"crossref","first-page":"R266","DOI":"10.1186\/ar4112","article-title":"Citrullinated fibronectin inhibits apoptosis and promotes the secretion of pro-inflammatory cytokines in fibroblast-like synoviocytes in rheumatoid arthritis","volume":"14","author":"Fan","year":"2012","journal-title":"Arthritis. Res. Ther."},{"issue":"16","key":"10.1016\/j.imlet.2017.11.004_bib0505","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0510","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/jaut.1994.1014","article-title":"Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases","volume":"7","author":"Marchini","year":"1994","journal-title":"J. Autoimmun."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0515","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0520","doi-asserted-by":"crossref","first-page":"489","DOI":"10.4049\/jimmunol.171.1.489","article-title":"Short term administration of costimulatory blockade and cyclophosphamide induces remission of systemic lupus erythematosus nephritis in NZB\/W F1 mice by a mechanism downstream of renal immune complex deposition","volume":"171","author":"Schiffer","year":"2003","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib0525","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.4049\/jimmunol.181.11.8145","article-title":"Differential expression and molecular associations of Syk in systemic lupus erythematosus T cells","volume":"181","author":"Krishnan","year":"2008","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0530","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.autrev.2009.02.035","article-title":"Interleukin 2 and systemic lupus erythematosus: beyond the transcriptional regulatory net abnormalities","volume":"9","author":"Gomez-Martin","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"Suppl. 3","key":"10.1016\/j.imlet.2017.11.004_bib0535","doi-asserted-by":"crossref","first-page":"iii65","DOI":"10.1136\/ard.2007.078493","article-title":"Systemic lupus erythematosus: new molecular targets","volume":"66","author":"Crispin","year":"2007","journal-title":"Ann. Rheum. Dis."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0540","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1007\/BF00918796","article-title":"Systemic lupus erythematosus: RNA-protein autoantigens, models of disease heterogeneity, and theories of etiology","volume":"11","author":"Harley","year":"1991","journal-title":"J. Clin. Immunol."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0545","doi-asserted-by":"crossref","first-page":"3019","DOI":"10.1172\/JCI119856","article-title":"An increased prevalence of Epstein-Barr virus infection in young patients suggests a possible etiology for systemic lupus erythematosus","volume":"100","author":"James","year":"1997","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0550","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1002\/1529-0131(200105)44:5<1122::AID-ANR193>3.0.CO;2-D","article-title":"Systemic lupus erythematosus in adults is associated with previous Epstein-Barr virus exposure","volume":"44","author":"James","year":"2001","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0555","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/gene.2009.39","article-title":"Recent insights into the genetic basis of systemic lupus erythematosus","volume":"10","author":"Moser","year":"2009","journal-title":"Genes Immun."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0560","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.autrev.2008.07.045","article-title":"Therapeutic potential of CD8+ cytotoxic T lymphocytes in SLE","volume":"8","author":"Puliaeva","year":"2009","journal-title":"Autoimmun. Rev."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0565","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/art.1780380408","article-title":"Impaired polyclonal T cell cytolytic activity. A possible risk factor for systemic lupus erythematosus","volume":"38","author":"Stohl","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"12","key":"10.1016\/j.imlet.2017.11.004_bib0570","doi-asserted-by":"crossref","first-page":"8761","DOI":"10.4049\/jimmunol.181.12.8761","article-title":"Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys","volume":"181","author":"Crispin","year":"2008","journal-title":"J. Immunol. (Baltimore, Md.: 1950)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0575","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S1568-9972(03)00086-7","article-title":"Immunoregulatory T cells in autoimmunity","volume":"3","author":"Crispin","year":"2004","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0580","doi-asserted-by":"crossref","first-page":"5878","DOI":"10.4049\/jimmunol.177.9.5878","article-title":"Aberrant phenotype and function of myeloid dendritic cells in systemic lupus erythematosus","volume":"177","author":"Ding","year":"2006","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0585","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cyto.2014.12.027","article-title":"Th1\/Th2\/Th17\/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: correlation with disease activity","volume":"72","author":"Talaat","year":"2015","journal-title":"Cytokine"},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0590","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1002\/art.24499","article-title":"Th17 and natural Treg cell population dynamics in systemic lupus erythematosus","volume":"60","author":"Yang","year":"2009","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0595","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1038\/ni.1741","article-title":"Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus","volume":"10","author":"Doreau","year":"2009","journal-title":"Nat. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0600","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/ar3433","article-title":"Mechanisms of B cell autoimmunity in SLE","volume":"13","author":"Dorner","year":"2011","journal-title":"Arthritis. Res. Ther."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0605","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1084\/jem.20042251","article-title":"Defective B cell tolerance checkpoints in systemic lupus erythematosus","volume":"201","author":"Yurasov","year":"2005","journal-title":"J. Exp. Med."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0610","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.1210\/jcem.86.6.7598","article-title":"Persistence of macroprolactinemia due to antiprolactin autoantibody before, during, and after pregnancy in a woman with systemic lupus erythematosus","volume":"86","author":"Leanos-Miranda","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0615","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1191\/096120301717165001","article-title":"Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus","volume":"10","author":"Blanco-Favela","year":"2001","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0620","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s12016-011-8256-0","article-title":"Prolactin and autoimmunity: hyperprolactinemia correlates with serositis and anemia in SLE patients","volume":"42","author":"Orbach","year":"2012","journal-title":"Clin. Rev. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0625","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1210\/edrv.19.3.0334","article-title":"Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice","volume":"19","author":"Bole-Feysot","year":"1998","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.imlet.2017.11.004_bib0630","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev.physiol.64.081501.131049","article-title":"Prolactin: the new biology of an old hormone","volume":"64","author":"Goffin","year":"2002","journal-title":"Annu. Rev. Physiol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0635","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0303-7207(95)03724-1","article-title":"Prolactin receptor gene expression in rat splenocytes and thymocytes from birth to adulthood","volume":"117","author":"Gunes","year":"1996","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.imlet.2017.11.004_bib0640","doi-asserted-by":"crossref","first-page":"287469","DOI":"10.1155\/2013\/287469","article-title":"Prolactin levels correlate with abnormal B cell maturation in MRL and MRL\/lpr mouse models of systemic lupus erythematosus-like disease","volume":"2013","author":"Legorreta-Haquet","year":"2013","journal-title":"Clin. Dev. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0645","first-page":"43","article-title":"Developmentally regulated expression of the novel cancer anti-apoptosis gene survivin in human and mouse differentiation","volume":"152","author":"Adida","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0650","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.autrev.2013.03.001","article-title":"Pathophysiology of myasthenia gravis with antibodies to the acetylcholine receptor, muscle-specific kinase and low-density lipoprotein receptor-related protein 4","volume":"12","author":"Verschuuren","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0655","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1097\/WCO.0b013e3283572588","article-title":"Myasthenia and the neuromuscular junction","volume":"25","author":"Gilhus","year":"2012","journal-title":"Curr. Opin. Neurol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0660","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/WCO.0b013e328364c079","article-title":"Myasthenia gravis and the neuromuscular junction","volume":"26","author":"Querol","year":"2013","journal-title":"Curr. Opin. Neurol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0665","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib0670","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/nri916","article-title":"Unravelling the pathogenesis of myasthenia gravis","volume":"2","author":"Vincent","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0675","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.autrev.2013.03.003","article-title":"Complement associated pathogenic mechanisms in myasthenia gravis","volume":"12","author":"Tuzun","year":"2013","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0680","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1002\/eji.1830220939","article-title":"Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor","volume":"22","author":"Loutrari","year":"1992","journal-title":"Eur. J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0685","doi-asserted-by":"crossref","first-page":"e102231","DOI":"10.1371\/journal.pone.0102231","article-title":"Survivin as a potential mediator to support autoreactive cell survival in myasthenia gravis: a human and animal model study","volume":"9","author":"Kusner","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2017.11.004_bib0690","series-title":"Multiple Sclerosis and Other Demyelinating Diseases, Inflammatory Diseases of the Brain","first-page":"3","author":"Bendszus","year":"2013"},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0695","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0700","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S1471-4914(00)01909-2","article-title":"Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy","volume":"7","author":"Lassmann","year":"2001","journal-title":"Trends Mol. Med."},{"issue":"51","key":"10.1016\/j.imlet.2017.11.004_bib0705","doi-asserted-by":"crossref","first-page":"21789","DOI":"10.1073\/pnas.0912152106","article-title":"IL-17-producing T cells can augment autoantibody-induced arthritis","volume":"106","author":"Jacobs","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"Pt. 12","key":"10.1016\/j.imlet.2017.11.004_bib0710","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1093\/brain\/awp289","article-title":"Phenotypical and functional characterization of T helper 17 cells in multiple sclerosis","volume":"132","author":"Brucklacher-Waldert","year":"2009","journal-title":"Brain J. Neurol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0715","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2353\/ajpath.2008.070690","article-title":"Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis","volume":"172","author":"Tzartos","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0720","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00002371-199210000-00004","article-title":"Proinflammatory and antiinflammatory cytokines in multiple sclerosis and central nervous system acquired immunodeficiency syndrome","volume":"12","author":"Merrill","year":"1992","journal-title":"J. Immunother."},{"issue":"1\u20133","key":"10.1016\/j.imlet.2017.11.004_bib0725","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/0022-510X(83)90201-0","article-title":"Immunohistological analysis of T lymphocyte subsets in the central nervous system in chronic progressive multiple sclerosis","volume":"62","author":"Booss","year":"1983","journal-title":"J. Neurol. Sci."},{"issue":"Pt. 8","key":"10.1016\/j.imlet.2017.11.004_bib0730","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1093\/brain\/120.8.1461","article-title":"The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion","volume":"120","author":"Gay","year":"1997","journal-title":"Brain J. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2017.11.004_bib0735","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0165-5728(96)00161-0","article-title":"Identification of an epitope derived from human proteolipid protein that can induce autoreactive CD8+ cytotoxic T lymphocytes restricted by HLA-A3: evidence for cross-reactivity with an environmental microorganism","volume":"73","author":"Honma","year":"1997","journal-title":"J. Neuroimmunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0740","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/ana.20890","article-title":"B lineage cells in the inflammatory central nervous system environment: migration, maintenance, local antibody production, and therapeutic modulation","volume":"59","author":"Meinl","year":"2006","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0745","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","article-title":"Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination","volume":"47","author":"Lucchinetti","year":"2000","journal-title":"Ann. Neurol."},{"issue":"9485","key":"10.1016\/j.imlet.2017.11.004_bib0750","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","article-title":"Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange","volume":"366","author":"Keegan","year":"2005","journal-title":"Lancet (London England)"},{"issue":"Pt. 6","key":"10.1016\/j.imlet.2017.11.004_bib0755","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1093\/brain\/aws105","article-title":"Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis","volume":"135","author":"Elliott","year":"2012","journal-title":"Brain J. Neurol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0760","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/1352458507087468","article-title":"Expression of the inhibitor of apoptosis protein family in multiple sclerosis reveals a potential immunomodulatory role during autoimmune mediated demyelination","volume":"14","author":"Hebb","year":"2008","journal-title":"Multiple Sclerosis (Houndmills, Basingstoke England)"},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0765","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S0952-7915(99)00037-0","article-title":"Apoptotic and effector pathways in autoimmunity","volume":"11","author":"Chervonsky","year":"1999","journal-title":"Curr. Opin. Immunol."},{"issue":"6805","key":"10.1016\/j.imlet.2017.11.004_bib0770","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1038\/35037728","article-title":"CD95's deadly mission in the immune system","volume":"407","author":"Krammer","year":"2000","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0775","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1212\/WNL.55.7.906","article-title":"Fas(t) track to apoptosis in MS: TNF receptors may suppress or potentiate CNS demyelination","volume":"55","author":"Segal","year":"2000","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0780","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1001\/archneur.59.7.1115","article-title":"Down-regulation of survivin expression in T lymphocytes after interferon beta-1a treatment in patients with multiple sclerosis","volume":"59","author":"Sharief","year":"2002","journal-title":"Arch. Neurol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0785","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1046\/j.1468-1331.2002.00454.x","article-title":"Upregulated survivin expression in activated T lymphocytes correlates with disease activity in multiple sclerosis","volume":"9","author":"Sharief","year":"2002","journal-title":"Eur. J. Neurol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0790","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0165-5728(01)00389-7","article-title":"Heightened expression of survivin in activated T lymphocytes from patients with multiple sclerosis","volume":"119","author":"Sharief","year":"2001","journal-title":"J. Neuroimmunol."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib0795","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0800","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1002\/art.11129","article-title":"Systemic sclerosis Th2 cells inhibit collagen production by dermal fibroblasts via membrane-associated tumor necrosis factor alpha","volume":"48","author":"Chizzolini","year":"2003","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0805","first-page":"1751","article-title":"Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis","volume":"151","author":"Mavalia","year":"1997","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0810","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/art.20315","article-title":"Is systemic sclerosis an antigen-driven T cell disease?","volume":"50","author":"Sakkas","year":"2004","journal-title":"Arthritis Rheum."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0815","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/CDLI.6.5.660-664.1999","article-title":"Increased levels of alternatively spliced interleukin 4 (IL-4delta2) transcripts in peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"6","author":"Sakkas","year":"1999","journal-title":"Clin. Diagn. Lab. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0820","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00403-004-0472-5","article-title":"Augmented production of transforming growth factor-beta by cultured peripheral blood mononuclear cells from patients with systemic sclerosis","volume":"296","author":"Hasegawa","year":"2004","journal-title":"Arch. Dermatol. Res."},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0825","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/1523-1747.ep12483971","article-title":"Stimulation of collagen and glycosaminoglycan production in cultured human adult dermal fibroblasts by recombinant human interleukin 6","volume":"97","author":"Duncan","year":"1991","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0830","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/1346-8138.13184","article-title":"B lymphocytes in systemic sclerosis: abnormalities and therapeutic targets","volume":"43","author":"Yoshizaki","year":"2016","journal-title":"J. Dermatol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0835","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/art.39437","article-title":"Breg cells are numerically decreased and functionally impaired in patients with systemic sclerosis","volume":"68","author":"Mavropoulos","year":"2016","journal-title":"Arthritis Rheumatol. (Hoboken N.J.)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0840","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.autrev.2015.10.005","article-title":"Systemic sclerosis: new evidence re-enforces the role of B cells","volume":"15","author":"Sakkas","year":"2016","journal-title":"Autoimmun. Rev."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0845","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2249.2009.04059.x","article-title":"Autoantibody-mediated regulation of B cell responses by functional anti-CD22 autoantibodies in patients with systemic sclerosis","volume":"159","author":"Odaka","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib0850","doi-asserted-by":"crossref","first-page":"6635","DOI":"10.4049\/jimmunol.165.11.6635","article-title":"Quantitative genetic variation in CD19 expression correlates with autoimmunity","volume":"165","author":"Sato","year":"2000","journal-title":"J. Immunol. (Baltimore Md.: 1950)"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib0855","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0889-857X(05)70297-0","article-title":"Antinuclear antibody in systemic sclerosis (scleroderma)","volume":"22","author":"Okano","year":"1996","journal-title":"Rheum. Dis. Clin. North Am."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0860","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00281-015-0513-5","article-title":"Functional autoantibodies in systemic sclerosis","volume":"37","author":"Gunther","year":"2015","journal-title":"Semin. Immunopathol."},{"issue":"25","key":"10.1016\/j.imlet.2017.11.004_bib0865","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1056\/NEJMoa052955","article-title":"Stimulatory autoantibodies to the PDGF receptor in systemic sclerosis","volume":"354","author":"Baroni","year":"2006","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0870","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1365-2249.2004.02615.x","article-title":"Autoantibody against matrix metalloproteinase-3 in patients with systemic sclerosis","volume":"138","author":"Nishijima","year":"2004","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0875","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/art.10361","article-title":"Autoantibodies to fibroblasts induce a proadhesive and proinflammatory fibroblast phenotype in patients with systemic sclerosis","volume":"46","author":"Chizzolini","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0880","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3899\/jrheum.091087","article-title":"Autoantibody against survivin in patients with systemic sclerosis","volume":"37","author":"Koike","year":"2010","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.imlet.2017.11.004_bib0885","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1186\/s13075-015-0785-0","article-title":"CD1a+ survivin+ dendritic cell infiltration in dermal lesions of systemic sclerosis","volume":"17","author":"Mokuda","year":"2015","journal-title":"Arthritis. Res. Ther."},{"issue":"9997","key":"10.1016\/j.imlet.2017.11.004_bib0890","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(14)61909-7","article-title":"Psoriasis","volume":"386","author":"Boehncke","year":"2015","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0895","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/sj.jid.5700008","article-title":"Keratinocyte apoptosis in epidermal development and disease","volume":"126","author":"Raj","year":"2006","journal-title":"J. Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0900","first-page":"182","article-title":"Apoptosis in psoriasis","volume":"17","author":"Kastelan","year":"2009","journal-title":"Acta dermatovenerologica Croatica: ADC"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0905","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00000372-200406000-00001","article-title":"Proliferation, apoptosis, and survivin expression in keratinocytic neoplasms and hyperplasias","volume":"26","author":"Bowen","year":"2004","journal-title":"Am. J. Dermatopathol."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0910","first-page":"260","article-title":"Angiopoietins, growth factors, and vascular morphology in early arthritis","volume":"30","author":"Fearon","year":"2003","journal-title":"J. Rheumatol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0915","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1111\/1523-1747.ep12681007","article-title":"Microcirculation in psoriatic skin","volume":"62","author":"Braverman","year":"1974","journal-title":"J. Invest. Dermatol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib0920","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/jid.2011.53","article-title":"I.W.F. van, J.D., Laman, F.J., Staal, L. van der Fits, Effective treatment of psoriasis with narrow-band UVB phototherapy is linked to suppression of the IFN and Th17 pathways","volume":"131","author":"Racz","year":"2011","journal-title":"J. Invest. Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0925","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/sj.jid.5701213","article-title":"Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17T cells","volume":"128","author":"Lowes","year":"2008","journal-title":"J. Invest. Dermatol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0930","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1111\/j.1365-2133.2006.07522.x","article-title":"Downregulation of the inhibitor of apoptosis protein survivin in keratinocytes and endothelial cells in psoriasis skin following infliximab therapy","volume":"155","author":"Markham","year":"2006","journal-title":"Br. J. Dermatol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0935","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jdermsci.2008.12.012","article-title":"VEGF, survivin and NOS overexpression in psoriatic skin: critical role of nitric oxide synthases","volume":"54","author":"Simonetti","year":"2009","journal-title":"J. Dermatol. Sci."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib0940","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1684\/ejd.2011.1496","article-title":"Effect of narrow band ultraviolet B on survivin in psoriatic skin lesions","volume":"21","author":"Nagui","year":"2011","journal-title":"Eur. J. Dermatol. EJD"},{"key":"10.1016\/j.imlet.2017.11.004_bib0945","doi-asserted-by":"crossref","first-page":"257059","DOI":"10.5402\/2012\/257059","article-title":"Expression of nuclear factor kappa B and survivin in psoriasis","volume":"2012","author":"Gunduz","year":"2012","journal-title":"ISRN Dermatol."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib0950","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1600-0560.2007.00841.x","article-title":"Evaluation of survivin and NF-kappaB in psoriasis, an immunohistochemical study","volume":"35","author":"Abdou","year":"2008","journal-title":"J. Cutan. Pathol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0955","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1053\/j.gastro.2011.10.001","article-title":"Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review","volume":"142","author":"Molodecky","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2017.11.004_bib0960","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/0-387-33778-4_15","article-title":"From immunogenic mechanisms to novel therapeutic approaches in inflammatory bowel disease","volume":"579","author":"Holtmann","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0965","first-page":"416","article-title":"Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune diseases, Nature clinical practice","volume":"2","author":"Fasano","year":"2005","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.imlet.2017.11.004_bib0970","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.semcdb.2014.06.004","article-title":"Regulation and pathophysiological role of epithelial turnover in the gut","volume":"35","author":"Gunther","year":"2014","journal-title":"Semin. Cell Dev. Biol."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib0975","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.gtc.2014.05.003","article-title":"Immunology of inflammatory bowel disease and molecular targets for biologics","volume":"43","author":"Dave","year":"2014","journal-title":"Gastroenterol. Clin. North Am."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib0980","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/77783","article-title":"Secretion of microbicidal alpha-defensins by intestinal Paneth cells in response to bacteria","volume":"1","author":"Ayabe","year":"2000","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib0985","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/mi.2013.73","article-title":"New targets for mucosal healing and therapy in inflammatory bowel diseases","volume":"7","author":"Neurath","year":"2014","journal-title":"Mucosal Immunol."},{"issue":"22","key":"10.1016\/j.imlet.2017.11.004_bib0990","doi-asserted-by":"crossref","first-page":"7061","DOI":"10.1073\/pnas.1415675112","article-title":"Th17 cells give rise to Th1 cells that are required for the pathogenesis of colitis","volume":"112","author":"Harbour","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.imlet.2017.11.004_bib0995","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20011956","article-title":"The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease","volume":"195","author":"Neurath","year":"2002","journal-title":"J. Exp. Med."},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib1000","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1084\/jem.188.10.1929","article-title":"Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4","volume":"188","author":"Boirivant","year":"1998","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib1005","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1136\/gutjnl-2013-305947","article-title":"IL-9 and its receptor are predominantly involved in the pathogenesis of UC","volume":"64","author":"Nalleweg","year":"2015","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.imlet.2017.11.004_bib1010","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1172\/JCI19836","article-title":"Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis","volume":"113","author":"Fuss","year":"2004","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib1015","doi-asserted-by":"crossref","first-page":"G7","DOI":"10.1152\/ajpgi.00079.2004","article-title":"Colorectal cancer in inflammatory bowel disease: the role of inflammation: american journal of physiology","volume":"287","author":"Itzkowitz","year":"2004","journal-title":"Gastrointestinal Liver Physiol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib1020","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ibd.21178","article-title":"Enhanced expression of proproliferative and antiapoptotic genes in ulcerative colitis-associated neoplasia","volume":"16","author":"Svec","year":"2010","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib1025","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1089\/gtmb.2015.0036","article-title":"Association of survivin promoter polymorphisms with inflammatory bowel disease and response to antitumor necrosis factor therapy","volume":"19","author":"Rapti","year":"2015","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib1030","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1053\/j.gastro.2012.06.039","article-title":"Increased levels of survivin, via association with heat shock protein 90, in mucosal T cells from patients with Crohn's disease","volume":"143","author":"de Souza","year":"2012","journal-title":"Gastroenterology"},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib1035","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0016-5085(99)70177-0","article-title":"Lamina propria T cells in Crohn's disease and other gastrointestinal inflammation show defective CD2 pathway-induced apoptosis","volume":"116","author":"Boirivant","year":"1999","journal-title":"Gastroenterology"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib1040","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.4049\/jimmunol.163.2.1081","article-title":"Resistance of Crohn\u2019s disease T cells to multiple apoptotic signals is associated with a Bcl-2\/Bax mucosal imbalance","volume":"163","author":"Ina","year":"1999","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib1045","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1084\/jem.20082683","article-title":"STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing","volume":"206","author":"Pickert","year":"2009","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib1050","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib1055","first-page":"534","article-title":"IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis","volume":"118","author":"Sugimoto","year":"2008","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.imlet.2017.11.004_bib1060","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology (Baltimore Md.)"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib1065","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1097\/MIB.0000000000000267","article-title":"High suppressor of cytokine signaling-3 expression impairs STAT3-dependent protective effects of interleukin-22 in ulcerative colitis in remission","volume":"21","author":"Xu","year":"2015","journal-title":"Inflamm. Bowel Dis."},{"issue":"3","key":"10.1016\/j.imlet.2017.11.004_bib1070","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.eururo.2013.10.039","article-title":"A randomised phase 2 study combining LY2181308 sodium (survivin antisense oligonucleotide) with first-line docetaxel\/prednisone in patients with castration-resistant prostate cancer","volume":"65","author":"Wiechno","year":"2014","journal-title":"Eur. Urol."},{"issue":"6","key":"10.1016\/j.imlet.2017.11.004_bib1075","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1097\/MPH.0b013e3182a8f58f","volume":"36","author":"Raetz","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib1080","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin-6 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treatment Rev."},{"key":"10.1016\/j.imlet.2017.11.004_bib1085","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1749-6632.2009.04911.x","article-title":"Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship?","volume":"1171","author":"Aggarwal","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib1090","doi-asserted-by":"crossref","first-page":"e22882","DOI":"10.4161\/jkst.22882","article-title":"STAT3 inhibitors for cancer therapy: have all roads been explored?","volume":"2","author":"Fagard","year":"2013","journal-title":"Jak-stat"},{"issue":"8","key":"10.1016\/j.imlet.2017.11.004_bib1095","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1136\/annrheumdis-2011-200968","article-title":"A CD4 T cell gene signature for early rheumatoid arthritis implicates interleukin 6-mediated STAT3 signalling, particularly in anti-citrullinated peptide antibody-negative disease","volume":"71","author":"Pratt","year":"2012","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.imlet.2017.11.004_bib1100","first-page":"25","article-title":"Type I\/II cytokines, JAKs, and new strategies for treating autoimmune diseases, Nature reviews","volume":"12","author":"Schwartz","year":"2016","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.imlet.2017.11.004_bib1105","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.jaad.2016.12.004","article-title":"Janus kinase inhibitors in dermatology: a systematic review","volume":"76","author":"Shreberk-Hassidim","year":"2017","journal-title":"J. Am. Acad. Dermatol."},{"issue":"7","key":"10.1016\/j.imlet.2017.11.004_bib1110","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1136\/annrheumdis-2016-210457","article-title":"Long-term safety of tofacitinib for the treatment of rheumatoid arthritis up to 8.5 years: integrated analysis of data from the global clinical trials","volume":"76","author":"Cohen","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"11","key":"10.1016\/j.imlet.2017.11.004_bib1115","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s40265-017-0772-7","article-title":"Erratum to: JAK-STAT signaling as a target for inflammatory and autoimmune diseases: current and future prospects","volume":"77","author":"Banerjee","year":"2017","journal-title":"Drugs"},{"issue":"2","key":"10.1016\/j.imlet.2017.11.004_bib1120","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2015.03.025","article-title":"IL-6 blockade reverses the abnormal STAT activation of peripheral blood leukocytes from rheumatoid arthritis patients","volume":"158","author":"Ortiz","year":"2015","journal-title":"Clin. Immunol. (Orlando, Fla.)"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303978?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247817303978?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T04:43:27Z","timestamp":1750999407000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247817303978"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":224,"alternative-id":["S0165247817303978"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.004","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Survivin and autoimmunity; the ins and outs","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2017.11.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}